ArticleJournal of clinical laboratory analysis2025
Can Albumin/Lymphocyte Ratio and MPV/Lymphocyte Ratio Serve as New Inflammatory Biomarkers in Patients With Hyperemesis Gravidarum?
Article in Journal of clinical laboratory analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Serum Platelet-Albumin Ratio in Hyperemesis Gravidarum: A Retrospective Comparative Study.International journal of women's health · 2026Article
- Association between the albumin-to-lymphocyte ratio and short-term mortality in critically Ill pediatric patients: a retrospective cohort study and machine learning analysis.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the diagnostic utility of the albumin/lymphocyte ratio (ALR) and mean platelet volume/lymphocyte ratio (MPVLR) novel inflammatory markers not previously studied in hyperemesis gravidarum (HG) as potential biomarkers in patients diagnosed with HG. PATIENTS AND
methodsA total of 68 first-trimester pregnant women with clinically diagnosed HG and 78 healthy pregnant controls were included. Systemic inflammatory markers including neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), albumin/fibrinogen ratio (AFR), fibrinogen/lymphocyte ratio (FLR), magnesium/lymphocyte ratio (MgLR), ALR, MPVLR, and systemic immune-inflammation index (SII) were calculated and compared between the two groups.
resultsLymphocyte counts and ketonuria levels were significantly higher in the HG group. Conversely, ALR and MPVLR values were significantly lower in the HG group. MPVLR was identified as a potential diagnostic marker for HG with a cutoff value of 4.569, yielding a sensitivity of 54.4% and specificity of 44.9%. ALR demonstrated a cutoff value of 22.853 with a sensitivity of 61.8% and specificity of 38.5%.
conclusionsIn contrast to the previous literature, PLR and NLR levels were not elevated in HG patients. However, ALR and MPVLR previously unexamined in this population were significantly lower, suggesting a potential role in HG pathophysiology. The findings underscore the complexity and dynamic nature of inflammatory responses in HG, warranting further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.